Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.13 USD | -0.24% | +0.11% | +7.03% |
Apr. 25 | Eastman Chemical beats estimates as destocking trends abate, affirms FY profit outlook | RE |
Apr. 25 | Eastman Chemical Q1 Adjusted Earnings, Revenue Fall; 2024 EPS Outlook Maintained | MT |
Evolution of the average Target Price on Eastman Chemical Company
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Eastman Chemical Company
Stifel Nicolaus | |
RBC Capital Markets | |
BofA Securities | |
KeyBanc Capital Markets | |
UBS | |
Deutsche Bank Securities | |
Redburn | |
Goldman Sachs | |
JPMorgan Chase | |
Piper Sandler | |
Barclays | |
Citigroup | |
Wells Fargo Securities | |
Mizuho Securities | |
Vertical Research | |
Scotiabank | |
Credit Suisse | |
Tudor Pickering Holt & Co. | |
Morgan Stanley | |
Jefferies & Co. | |
Berenberg Bank | |
Wolfe Research |
EPS Revisions
- Stock Market
- Equities
- EMN Stock
- Consensus Eastman Chemical Company